Short Description:
CAS number:665-66-7
Molecular formula: C10H18ClN
Molecular weight: 187.71
Chemical structure:
| Basic Information | |
| Product name | Adamantanamine hydrochloride |
| CAS No. | 665-66-7 |
| Appearance | White Fine Crystalline Powder |
| Grade | Pharma Grade |
| Water Solubility | Soluble |
| Storage | Store below +30°C. |
| Shelf Life | 2 Years |
| Package | 25kg/Drum |
Product Description
Amantadine hydrochloride, also known as amantadine hydrochloride or tricyclodecane, is used in patients with primary tremor paralysis and tremor paralysis who cannot tolerate levodopa treatment, drug-induced extrapyramidal reactions, carbon monoxide poisoning, Parkinson's syndrome, and respiratory infections caused by the Asian A-II influenza virus.
Amantadine hydrochloride is a symmetrical tricyclic amine that can inhibit virus penetration into host cells, affect virus shedding, inhibit its reproduction, and play a therapeutic and preventive role in viral infections
Clinical Use
Adamantanamine hydrochloride can effectively prevent and treat various infections of influenza A virus in clinical practice. Using this product as a preventive medicine during the influenza epidemic period can achieve a protection rate of 50% to 79%. For those who have already developed the disease, if administered within 48 hours, it can effectively treat respiratory symptoms caused by the type A influenza virus. After entering the brain tissue, it can promote the release of dopamine or delay its metabolism, exerting an anti tremor and paralysis effect. It has a significant therapeutic effect on tremor paralysis and has a good effect on relieving tremor and stiffness. After 48 hours of medication, the effect is obvious and it has a good antipyretic effect when used in combination with antibiotics for various inflammations, sepsis, viral pneumonia, etc. Primary tremor paralysis and tremor paralysis syndrome after encephalitis and cerebral arteriosclerosis, prevention and treatment of influenza A virus.
